Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18
No follow-up studies have been conducted since this study, which was published in 2011
Although the use of exosomes as a delivery system has its drawback (for example, quickly eliminating by the reticuloendothelial system, lack of efficient encapsulation methods, and potential immune responses), exosomes targeted at tumors may allow systemic administration of miRNA as cancer treatment and are thus worthy of attention
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
GHK-Cu a small tripeptide that your body manufactures naturally is involved in tissue repair, collagen synthesis, anti-inflammatory signaling, and a remarkable range of gene expression patterns associated with regeneration
References 1.Li L., Hoffman R.M
Insurance is not billed directly
US$ 28.07
US$ 25.57
US$ 27.32
US$ 22.23
US$ 21.56
